Literature DB >> 659332

Purification and characterization of an aminoglycoside inactivating enzyme from Staphylococcus epidermidis FK109 that nucleotidylates the 4'- and 4''-hydroxyl groups of the aminoglycoside antibiotics.

P Santanam, F H Kayser.   

Abstract

The resistance to aminoglycoside antibiotics in Staphylococcus epidermidis FK109, is mediated by an enzyme that catalyzes transfer of the nucleotide monophosphate moiety from the nucleotide triphosphates, either to the 4'-hydroxyl group, that is in the equatorial plane of the aminoglycoside molecule. The enzyme, modifying the two sites, appears as a single and homogeneous entity in affinity chromatography, in chromatography on DEAE-Sepharose CL-6B, in isoelectric focusing and in gel-filtration. It requires divalent cations, notably Mg++, and dithiothreitol for optimal adenylylation. It has a molecular weight of 46,770 and an isoelectric point of 5.0. The ability of the enzyme ANT (4', 4'') to modify the two hydroxyl groups of aminoglycoside molecules, enables it to have a spectrum of substrates that surpasses, in range, the substrate spectrum of all the aminoglycoside-modifying enzymes which have been characterized hitherto.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 659332     DOI: 10.7164/antibiotics.31.343

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  13 in total

1.  Occurrence of 4'-O-aminoglycoside-nucleotidyltransferase in clinical strains of Enterobacteriaceae.

Authors:  M Kettner; T Macicková; V Krcméry
Journal:  Infection       Date:  1989 Mar-Apr       Impact factor: 3.553

Review 2.  Plasmid-determined resistance to antimicrobial drugs and toxic metal ions in bacteria.

Authors:  T J Foster
Journal:  Microbiol Rev       Date:  1983-09

Review 3.  Aminoglycoside modifying enzymes.

Authors:  Maria S Ramirez; Marcelo E Tolmasky
Journal:  Drug Resist Updat       Date:  2010-09-15       Impact factor: 18.500

4.  Nucleotide sequence analysis and DNA hybridization studies of the ant(4')-IIa gene from Pseudomonas aeruginosa.

Authors:  K J Shaw; H Munayyer; P N Rather; R S Hare; G H Miller
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

Review 5.  Versatility of aminoglycosides and prospects for their future.

Authors:  Sergei B Vakulenko; Shahriar Mobashery
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

6.  Failure of the disk diffusion test to detect tobramycin resistance in kanamycin-resistant Escherichia coli strains.

Authors:  P Santanam
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

Review 7.  Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes.

Authors:  K J Shaw; P N Rather; R S Hare; G H Miller
Journal:  Microbiol Rev       Date:  1993-03

8.  Purification and characterization of aminoglycoside-modifying enzymes from Staphylococcus aureus and Staphylococcus epidermidis.

Authors:  K Ubukata; N Yamashita; A Gotoh; M Konno
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

9.  New plasmid-mediated aminoglycoside adenylyltransferase of broad substrate range that adenylylates amikacin.

Authors:  R G Coombe; A M George
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

10.  Appearance of amikacin and tobramycin resistance due to 4'-aminoglycoside nucleotidyltransferase [ANT(4')-II] in gram-negative pathogens.

Authors:  G A Jacoby; M J Blaser; P Santanam; H Hächler; F H Kayser; R S Hare; G H Miller
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.